ArticleNephron2024

Continuous Erythropoietin Receptor Activator for the Treatment of Chronic Dialysis Patients with Renal Anemia in Daily Clinical Practice in Poland: A Non-Interventional, Multi-Center, Pragmatic NAVIGO Trial.

Michał Nowicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.